Line 15: | Line 15: | ||
<!-- Page Content --> | <!-- Page Content --> | ||
<div class="container"> | <div class="container"> | ||
− | < | + | <h3> <u> Our Product </u> </h3> |
− | + | SilenshR is a synthetic biology solution that leverages the innate capacity of bacteria to colonize the hypoxic and immune-privileged cores of tumors conferring specificity to a systemic therapeutic approach. Once the SilenshR E. coli reach a cell density of 2*10^11 colony forming units (cfu) per milliliter within the tumor, genetic circuits are activated allowing SilenshR recombinants to invade cancer cells and release a short hairpin RNA (shRNA) targeting an expressed oncogene thereby halting the unchecked cellular proliferation of cancer. By circumventing the need for systemic delivery of chemotherapy and the inevitable off-target cytotoxicity, SilenshR keeps the immune system intact, spares the digestive epithelial lining from damage and relieves anxiety surrounding hair loss. | |
− | + | ||
+ | |||
</div> | </div> | ||
Revision as of 03:04, 2 November 2017
Entrepreneurship
Our first steps towards a business model
Our Product
SilenshR is a synthetic biology solution that leverages the innate capacity of bacteria to colonize the hypoxic and immune-privileged cores of tumors conferring specificity to a systemic therapeutic approach. Once the SilenshR E. coli reach a cell density of 2*10^11 colony forming units (cfu) per milliliter within the tumor, genetic circuits are activated allowing SilenshR recombinants to invade cancer cells and release a short hairpin RNA (shRNA) targeting an expressed oncogene thereby halting the unchecked cellular proliferation of cancer. By circumventing the need for systemic delivery of chemotherapy and the inevitable off-target cytotoxicity, SilenshR keeps the immune system intact, spares the digestive epithelial lining from damage and relieves anxiety surrounding hair loss.